Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Rogers Corp. (NY: ROG)
47.57 USD  +0.58 (+1.23%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Rogers Corp.
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
20 21 Next >
MARKET PULSE-US stocks to watch: Eastman, Ford, Procter & Gamble
January 27, 2012
Eastman, which makes chemicals, plastics and fiber, agreed to buy specialty chemical maker Solutia Inc for about $3.38 billion in cash and stock to expand its presence in Asia Pacific. Read More
category companyNews
from Reuters: Company News
MARKET PULSE-US stocks to watch: Time Warner, Netflix
January 26, 2012
The No. 2 U.S. cable provider's quarterly profit rose as it added more residential customers for its broadband services than it had expected. Read More
category companyNews
from Reuters: Company News
Supply of two Roche drugs in question, U.S. plant trouble
January 25, 2012
ZURICH, Jan 25 (Reuters) - Two Roche drugs may be in short supply in some countries due to manufacturing problems at a U.S. plant, a spokesman said on Wednesday, adding that the group does not expect... Read More
category companyNews
from Reuters: Company News
MARKET PULSE-US stocks to watch: Apple, Yahoo, Boeing
January 25, 2012
Jan 25 (Reuters) - Some U.S. stocks to watch on Wednesday: Read More
category companyNews
from Reuters: Company News
Deals of the day -- mergers and acquisitions
January 25, 2012
Jan 25 (Reuters) - The following bids, mergers, acquisitions and disposals involving European, U.S. and Asian companies were reported by 1000 GMT on Wednesday. Read More
category companyNews
from Reuters: Company News
PRESS DIGEST - Wall Street Journal - Jan 25
January 25, 2012
Jan 25 (Reuters) - The following were the top stories in The Wall Street Journal on Wednesday. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category companyNews
from Reuters: Company News
Illumina CEO: no comment on Roche $5.7 bln takeover offer
January 24, 2012
Jan 25 (Reuters) - The President and CEO of U.S. gene sequencing device maker Illumina Inc said he had no comment to make about a $5.7 billion cash takeover offer for the company by Swiss drugmaker... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Roche offering to buy Illumina for about $5.7 bln
January 24, 2012
Jan 24 (Reuters) - Swiss drugmaker Roche Holding AG said it is offering about $5.7 billion in cash to buy U.S. gene sequencing device maker Illumina Inc, in what could potentially become a hostile... Read More
category companyNews
from Reuters: Company News
UPDATE 1-India's Ind-Swift to sell Roche diagnostic kits, shares jump
January 13, 2012
MUMBAI, Jan 13 (Reuters) - Indian drugmaker Ind-Swift Ltd said on Friday it will sell heart attack detection kits developed by Swiss firm Roche Holding AG, sending Ind Swift's shares up more than 9... Read More
category companyNews
from Reuters: Company News
CORRECTED-UPDATE 1-Regeneron posts '11 Eylea sales of $24-25 mln
January 12, 2012
SAN FRANCISCO, Jan 9 (Reuters) - Sales of Eylea, the eye drug launched last November by Regeneron Pharmaceuticals Inc , totaled between $24 million and $25 million through the end of last year, the... Read More
category companyNews
from Reuters: Company News
CORRECTED-BRIEF-Xenon to collaborate with Genentech on discovery of novel
January 09, 2012
* To collaborate with Genentech on discovery of novel targeted pain therapeutics Read More
category companyNews
from Reuters: Company News
Europe's resurgent pharma stocks ripe for retreat
January 09, 2012
PARIS, Jan 9 (Reuters) - Europe's pharmaceutical stocks are ripe for a serious pull-back after an 18 percent jump in six weeks, chartists said on Monday, although the retreat would likely be a... Read More
category companyNews
from Reuters: Company News
ThinkEquity Downgrades Rogers Corp (ROG) to Hold
January 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7063736 for the full story. Read More
from StreetInsider.com News Articles
Roche had lower sales in Europe, stable U.S.-report
December 25, 2011
* CEO says is seeing double-digit sales growth in Asia-paper Read More
category companyNews
from Reuters: Company News
The Week in Review: Hutchison MediPharma and AstraZeneca Partner on Cancer Drug
December 24, 2011
Hutchison MediPharma and AstraZeneca formed a partnership to develop a novel cancer molecule; Hua Medicine in-licensed global rights to diabetes treatment program; Shunfeng Pharma is auctioning itself... Read More
from ChinaBio® Today
JMP Securities Starts Rogers Corp (ROG) at Market Outperform
December 21, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7035611 for the full story. Read More
from StreetInsider.com News Articles
Hua Medicine In-licenses Diabetes Drug Candidate from Roche
December 20, 2011
Hua Medicine has in-licensed global rights to Roche’s glucokinase activator program (GKA), a potential treatment for diabetes. GKA is a novel, small molecule activator of the glucokinase enzyme, which... Read More
from ChinaBio® Today
UPDATE 2-Roche melanoma drug wins European green light
December 16, 2011
LONDON, Dec 16 (Reuters) - European regulators have recommended approval of a targeted melanoma drug from Swiss group Roche Holding AG, opening the way to a new treatment option for patients with the... Read More
category companyNews
from Reuters: Company News
GSK drug fails to hit goal in breast cancer trial
December 09, 2011
LONDON, Dec 9 (Reuters) - GlaxoSmithKline's drug Tykerb failed to hit its goal in a clinical trial testing its role in women with early breast cancer, dimming hopes for its use in this setting. Read More
category companyNews
from Reuters: Company News
UPDATE 1-New Roche drug could alter breast cancer treatment
December 07, 2011
* Roche aims to shift standard care for HER2 breast cancer Read More
category companyNews
from Reuters: Company News
New Roche drug could alter breast cancer treatment
December 07, 2011
* Roche aims to shift standard care for HER2 breast cancer Read More
category companyNews
from Reuters: Company News
Abbott dismisses talk of pharma unit sale
December 05, 2011
LONDON, Dec 5 (Reuters) - Abbott Laboratories has no intention of selling its soon-to-be-separated pharmaceuticals business to another drugmaker and any potential bidder would struggle to persuade... Read More
category companyNews
from Reuters: Company News
Rodman & Renshaw Starts Rogers Corp (ROG) at Market Outperform
December 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6990777 for the full story. Read More
from StreetInsider.com News Articles
Netflix (NFLX) Will Cost You More than You Think
November 30, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6984772 for the full story. Read More
from StreetInsider.com News Articles
CJS Securities Starts Rogers Corp (ROG) at Market Outperform
November 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6977414 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 6-Gilead bets $11 bln on hepatitis in Pharmasset deal
November 21, 2011
Nov 21 (Reuters) - Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge and risky bet on the next generation of hepatitis C treatments. Read More
category companyNews
from Reuters: Company News
REFILE-UPDATE 3-US revokes approval of Avastin for breast cancer
November 18, 2011
WASHINGTON, Nov 18 (Reuters) - U.S. drug regulators withdrew their approval of Roche's Avastin for breast cancer, saying the drug was not effective enough to justify its risks even if patients believe... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Amgen signs 7-yr anemia drug contract with DaVita
November 18, 2011
Nov 18 (Reuters) - Amgen Inc reached a seven-year contract to supply DaVita Inc with nearly all of the anemia drugs needed by the dialysis clinic operator, locking up nearly a third of the U.S. market... Read More
category companyNews
from Reuters: Company News
Roche still sees peak Avastin sales 7 bln francs
November 18, 2011
LONDON, Nov 18 (Reuters) - Swiss drugmaker Roche still expects its cancer drug Avastin to generate peak annual sales of 7 billion Swiss francs ($7.6 billion), despite Friday's decision by U.S.... Read More
category companyNews
from Reuters: Company News
RPT-Medicare to still cover Avastin for breast cancer
November 18, 2011
Nov 18 (Reuters) - The Medicare federal insurance program for the elderly and disabled will continue paying for Roche Holding's drug Avastin for breast cancer, despite the health regulator's decision... Read More
category companyNews
from Reuters: Company News
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
20 21 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here